Related Experiment Videos
[Meningeal cryptococcosis. Retrospective study of 7 cases]
1Département de Neurologie, Faculté de Médecine de Ho Chi Minh Ville, Vietnam.
Revue Neurologique
|June 1, 1996
Summary
This study reviewed 7 cryptococcal meningitis cases, finding India ink tests and chronic meningitis features crucial for diagnosis. Treatment with amphotericin B showed a low cure rate, highlighting challenges in managing this serious fungal infection.
Area of Science:
- Neurology
- Infectious Diseases
- Mycology
Background:
- Cryptococcal meningitis is a serious fungal infection, particularly affecting immunocompromised individuals.
- Early and accurate diagnosis is critical for effective management and improved patient outcomes.
- Understanding the clinical and cerebrospinal fluid (CSF) features aids in differentiating it from other meningitis types.
Observation:
- The analysis reviewed medical records of 7 patients diagnosed with cryptococcal meningitis.
- Diagnostic criteria relied on India ink preparation identifying Cryptococcus neoformans in CSF and chronic meningitis features.
- Treatment exclusively involved amphotericin B, with varied administration routes.
Findings:
- Only India ink preparation and chronic meningitis clinical features were used for diagnosis in these cases.
- Amphotericin B was the sole therapeutic agent employed.
- A low cure rate was observed, with only 2 out of 7 patients achieving complete recovery; 5 patients deceased.
- Intravenous and intrathecal amphotericin B administration was used in the two successfully treated patients.
Implications:
- The diagnostic approach in these cases was limited, underscoring the need for comprehensive diagnostic strategies.
- The high mortality rate associated with amphotericin B treatment emphasizes the severity of cryptococcal meningitis.
- Combined intravenous and intrathecal amphotericin B may improve treatment success, warranting further investigation.